We are live on ! Find out more
PIM

Profit Investment Management Portfolio holdings

AUM $24.7M
1-Year Est. Return 21.29%
This Fund
S&P 500
This Quarter Est. Return
+11.17%
1 Year Est. Return
+21.29%
3 Year Est. Return
+100.77%
5 Year Est. Return
+135.15%
10 Year Est. Return
+678.27%
AUM
$162M
AUM Growth
+$18.7M
Cap. Flow
+$6.66M
Cap. Flow %
4.12%
Top 10 Hldgs %
28.87%
Holding
91
New
8
Increased
43
Reduced
17
Closed
3

Top Sells

Rank Stock Value
1
EVH icon
Evolent Health
EVH
+$1.47M
2
SAM icon
Boston Beer
SAM
+$734K
3
LOGM
LogMein, Inc.
LOGM
+$671K
4
RTX icon
RTX Corp
RTX
+$540K
5
COST icon
Costco
COST
+$536K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 20.09%
2 Technology 18.58%
3 Healthcare 18.4%
4 Industrials 13.25%
5 Financials 9.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVTA
1
DELISTED
Invitae Corporation
NVTA
$6.35M 3.92%
146,448
-15,074
-9% -$514K
FDS icon
2
Factset
FDS
$10.6B
$5.34M 3.3%
15,941
+588
+4% +$203K
ROL icon
3
Rollins
ROL
$17.8B
$5.01M 3.1%
138,735
+6,831
+5% +$236K
SAM icon
4
Boston Beer
SAM
$1.88B
$5.01M 3.09%
5,667
-929
-14% -$734K
CROX icon
5
Crocs
CROX
$6.17B
$4.71M 2.91%
110,214
+6,710
+6% +$260K
RS icon
6
Reliance Steel & Aluminium
RS
$21.5B
$4.52M 2.79%
44,291
+2,166
+5% +$220K
TTWO icon
7
Take-Two Interactive
TTWO
$45.8B
$4.28M 2.64%
25,891
+1,237
+5% +$201K
GIII icon
8
G-III Apparel Group
GIII
$1.44B
$4.05M 2.5%
308,884
+18,488
+6% +$222K
WCC
9
WESCO International
WCC
$16.5B
$3.86M 2.38%
87,628
+4,729
+6% +$202K
EPAM icon
10
EPAM Systems
EPAM
$5.41B
$3.6M 2.22%
11,134
+683
+7% +$204K
AAPL icon
11
Apple
AAPL
$4.63T
$3.56M 2.2%
30,731
-1,737
-5% -$190K
CALY
12
Callaway Golf Company
CALY
$2.92B
$3.46M 2.14%
180,853
+13,363
+8% +$251K
FICO icon
13
Fair Isaac
FICO
$25B
$3.26M 2.02%
7,668
+454
+6% +$193K
PLXS icon
14
Plexus
PLXS
$6.47B
$3.17M 1.96%
44,936
+2,617
+6% +$192K
MSFT icon
15
Microsoft
MSFT
$3.59T
$3.13M 1.94%
14,897
+88
+0.6% +$18.5K
FWRD icon
16
Forward Air
FWRD
$639M
$3.11M 1.92%
54,246
+4,091
+8% +$224K
V icon
17
Visa
V
$690B
$2.99M 1.85%
14,966
-694
-4% -$139K
NKE icon
18
Nike
NKE
$61.1B
$2.96M 1.83%
23,576
-319
-1% -$34.2K
PETS icon
19
PetMed Express
PETS
$39.2M
$2.89M 1.78%
91,328
+7,574
+9% +$251K
JBTM
20
JBT Marel
JBTM
$6.02B
$2.86M 1.77%
31,076
+2,200
+8% +$211K
NVST icon
21
Envista
NVST
$4.57B
$2.77M 1.71%
+112,134
New +$2.58M
NSP icon
22
Insperity
NSP
$2.05B
$2.75M 1.7%
41,903
+2,840
+7% +$189K
WGO icon
23
Winnebago Industries
WGO
$916M
$2.72M 1.68%
52,595
+3,619
+7% +$208K
VNDA icon
24
Vanda Pharmaceuticals
VNDA
$336M
$2.53M 1.56%
261,891
+70,901
+37% +$758K
HD icon
25
Home Depot
HD
$348B
$2.44M 1.51%
8,787
-163
-2% -$44.2K

Similar funds

Profit Investment Management's Q3 2020 Portfolio in Review

As of Q3 2020, Profit Investment Management held 91 positions worth $162M, up 13% from $143M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Profit Investment Management deployed $6.66M of net new capital in Q3 2020, opening 8 new positions and adding to 43 existing holdings. Its largest new stake was Envista: 112,134 shares worth $2.77M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 20% of assets, up from 19% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Boston Beer, an estimated $734K trimmed.

  • Profit Investment Management's largest Q3 2020 buy was Envista: 112,134 shares worth $2.77M.
  • Profit Investment Management added most to Vanda Pharmaceuticals in Q3 2020, an estimated $758K increase.
  • Profit Investment Management's biggest Q3 2020 reduction was Boston Beer, cutting an estimated $734K.
  • Profit Investment Management fully exited Evolent Health in Q3 2020, selling an estimated $1.47M.
  • Profit Investment Management's ten largest holdings make up 29% of its $162M portfolio in Q3 2020.
  • Profit Investment Management opened 8 new positions and closed 3 in Q3 2020.
  • Profit Investment Management's portfolio value rose 13% quarter-over-quarter to $162M.

Based on Profit Investment Management's 13F filing for Q3 2020, filed 9 Nov 2020.